https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-3663
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-21 / World J. Gastroenterol. 2019 Jul;25(27):3649-36632019-07-21 00:00:002019-07-21 00:00:00Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-18 / Oncoimmunology 2019;8(11):e1638212
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-18 / Oncoimmunology 2019;8(11):e16382122019-07-18 00:00:002019-07-18 00:00:00Trial watch: dendritic cell vaccination for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-12 / Pharmacol Res 2019 09;147:104353
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-12 / Pharmacol Res 2019 09;147:1043532019-07-12 00:00:002019-07-12 00:00:00Targeting regulatory T cells by curcumin: A potential for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-31672019-07-07 00:00:002019-07-07 00:00:00Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-07-01 / In Vivo 2019 Jul-Aug;33(4):983-997
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-07-01 / In Vivo 2019 Jul-Aug;33(4):983-9972019-07-01 00:00:002019-07-01 00:00:00Chemoprevention of Breast Cancer With Vitamins and Micronutrients: A Concise Review
